Home > News
|
Clinical Trials Update: June 16, 2004 |
|
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
Lung Cancer
A study is under way comparing two medications for the treatment of non-small cell lung cancer that is refractory or resistant to platinum and Taxotere chemotherapy.
Volunteers 18 years old or older who have histologically confirmed non-curable non-small cell lung cancer with surgery, radiology, or combined modality chemoradiation and who have failed two prior chemotherapy regimens including a platinum based therapy and Taxotere may be eligible to participate.
Research sites are located throughout the United States.
More Information
Please see http://www.centerwatch.com/patient/studies/cat34.html.
-----
Kidney Disease
A research study is being conducted for a medication to treat kidney disease.
Volunteers 18 to 75 years old who have been diagnosed with kidney disease, have no history of dialysis or transplants and are able to participate in overnight, in-house stays may be eligible to participate.
The research site is in Austin, Tex.
More Information
Please see http://www.centerwatch.com/patient/studies/cat226.html.
-----
Allergy (Pediatric)
A is under way to evaluate an experimental allergy medication.
Children 2-5 years-old may be eligible to participate.
There is a four week study treatment period with the option to continue for an additional 6 months.
The research site is in San Antonio, Tex.More Information
Please see http://www.centerwatch.com/patient/studies/cat432.html.
-----
Copyright 2004 CenterWatch. All rights reserved.
Copyright © 2004 ScoutNews, LLC. All rights reserved.
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder® does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder® health library.
